Long-term outcome of patients with steroid-refractory acute severe UC treated with ciclosporin or infliximab
Long-term outcome of patients with steroid-refractory acute severe UC treated with ciclosporin or infliximab is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Long-term outcome of patients with steroid-refractory acute severe UC treated with ciclosporin or infliximab have?
Long-term outcome of patients with steroid-refractory acute severe UC treated with ciclosporin or infliximab has 160 citations in the OpenAlex counts ScholarIQ stores.
When was Long-term outcome of patients with steroid-refractory acute severe UC treated with ciclosporin or infliximab published?
Long-term outcome of patients with steroid-refractory acute severe UC treated with ciclosporin or infliximab has 2017 year in the ScholarIQ index.
What is the open-access status of Long-term outcome of patients with steroid-refractory acute severe UC treated with ciclosporin or infliximab?
Long-term outcome of patients with steroid-refractory acute severe UC treated with ciclosporin or infliximab has green oa status in the ScholarIQ index.
What is the DOI of Long-term outcome of patients with steroid-refractory acute severe UC treated with ciclosporin or infliximab?
The DOI for Long-term outcome of patients with steroid-refractory acute severe UC treated with ciclosporin or infliximab is on the source record.
What is the PMID of Long-term outcome of patients with steroid-refractory acute severe UC treated with ciclosporin or infliximab?
The PMID for Long-term outcome of patients with steroid-refractory acute severe UC treated with ciclosporin or infliximab is on the source record.
What is the OpenAlex record for Long-term outcome of patients with steroid-refractory acute severe UC treated with ciclosporin or infliximab?
The OpenAlex for Long-term outcome of patients with steroid-refractory acute severe UC treated with ciclosporin or infliximab is on the source record.